Glioblastome multiforme (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Glioblastome multiforme" in French language version.

refsWebsite

Global rank French rank

6nejm.org

2,374^th place

298^th place

4nih.gov

4^th place

12^th place

4doi.org

2^nd place

3^rd place

3issn.org

57^th place

4^th place

3wikipedia.org

low place

2jamanetwork.com

2,650^th place

689^th place

1sciencedirect.com

149^th place

80^th place

1mdpi.com

2,912^th place

1,010^th place

1oncolink.org

low place

1oxfordjournals.org

1,389^th place

508^th place

doi.org

dx.doi.org

(en) Athina-Maria Aloizou et Dimitra Aloizou, « ONC201 for Glioma Treatment: Adding an Important Weapon to Our Arsenal », Neuroglia, vol. 4, n^o 1,‎ mars 2023, p. 28–33 (ISSN 2571-6980, DOI 10.3390/neuroglia4010003, lire en ligne, consulté le 31 juillet 2023)
(en) Maximilien Vermandel, Clément Dupont, Fabienne Lecomte et Henri-Arthur Leroy, « Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial », Journal of Neuro-Oncology, vol. 152, n^o 3,‎ 1^er mai 2021, p. 501–514 (ISSN 1573-7373, DOI 10.1007/s11060-021-03718-6, lire en ligne, consulté le 5 mai 2021)
(en) Kenneth A. Schwartz, Mary Noel, Michele Nikolai et Howard T. Chang, « Investigating the Ketogenic Diet As Treatment for Primary Aggressive Brain Cancer: Challenges and Lessons Learned », Frontiers in Nutrition, vol. 5,‎ 23 février 2018 (ISSN 2296-861X, PMID 29536011, PMCID PMC5834833, DOI 10.3389/fnut.2018.00011, lire en ligne, consulté le 27 juin 2018).

doi.org

(en) Maximilien Vermandel, Clément Dupont, Fabienne Lecomte et Henri-Arthur Leroy, « Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial », Journal of Neuro-Oncology, vol. 152, n^o 3,‎ 1^er mai 2021, p. 501–514 (ISSN 1573-7373, DOI 10.1007/s11060-021-03718-6, lire en ligne, consulté le 5 mai 2021)

issn.org

portal.issn.org

(en) Athina-Maria Aloizou et Dimitra Aloizou, « ONC201 for Glioma Treatment: Adding an Important Weapon to Our Arsenal », Neuroglia, vol. 4, n^o 1,‎ mars 2023, p. 28–33 (ISSN 2571-6980, DOI 10.3390/neuroglia4010003, lire en ligne, consulté le 31 juillet 2023)
(en) Maximilien Vermandel, Clément Dupont, Fabienne Lecomte et Henri-Arthur Leroy, « Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial », Journal of Neuro-Oncology, vol. 152, n^o 3,‎ 1^er mai 2021, p. 501–514 (ISSN 1573-7373, DOI 10.1007/s11060-021-03718-6, lire en ligne, consulté le 5 mai 2021)
(en) Kenneth A. Schwartz, Mary Noel, Michele Nikolai et Howard T. Chang, « Investigating the Ketogenic Diet As Treatment for Primary Aggressive Brain Cancer: Challenges and Lessons Learned », Frontiers in Nutrition, vol. 5,‎ 23 février 2018 (ISSN 2296-861X, PMID 29536011, PMCID PMC5834833, DOI 10.3389/fnut.2018.00011, lire en ligne, consulté le 27 juin 2018).

jamanetwork.com

Schaff LR, Mellinghoff IK, Glioblastoma and Other Primary Brain Malignancies in Adults: A Review, JAMA, 2023;329:574–587
Stupp R, Taillibert S, Kanner A et al. {https://jamanetwork.com/journals/jama/fullarticle/2666504 Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial], JAMA, 2017;318:2306-2316

mdpi.com

(en) Athina-Maria Aloizou et Dimitra Aloizou, « ONC201 for Glioma Treatment: Adding an Important Weapon to Our Arsenal », Neuroglia, vol. 4, n^o 1,‎ mars 2023, p. 28–33 (ISSN 2571-6980, DOI 10.3390/neuroglia4010003, lire en ligne, consulté le 31 juillet 2023)

nejm.org

(en) Wen PY, Kesari S, « Malignant gliomas in adults » N Engl J Med. 2008;359:492-507.
(en) Bredel M, Scholtens DM, Yadav AK, « NFKBIA Deletion in Glioblastomas » N Eng J Med. 2011;364:627-37.
Stupp R, Mason WP, van den Bent MJ et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med. 2005;352:987-996
Hegi ME, Diserens AC, Gorlia T et al. MGMT gene silencing and benefit from temozolomide in glioblastoma, N Engl J Med, 2005;352:997-1003
(en) Stupp R, Mason WP, van den Bent MJ et al. « Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma » N Engl J Med. 2005;352:987-996.
(en) Hegi ME, Diserens AC, Gorlia T et al. « MGMT gene silencing and benefit from temozolomide in glioblastoma » N Engl J Med. 2005;352:997-1003.

nih.gov

ncbi.nlm.nih.gov

(en) de Wit MC, de Bruin HG, Eijkenboom W, Sillevis Smitt PA, van den Bent MJ, « Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression », Neurology. 2004;63:535-537.
(en) Briceño E, Reyes S, Sotelo J, « Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine », Neurosurg Focus (de), vol. 14, n^o 2,‎ 2003, e3. (PMID 15727424) modifier.
(en) Kenneth A. Schwartz, Mary Noel, Michele Nikolai et Howard T. Chang, « Investigating the Ketogenic Diet As Treatment for Primary Aggressive Brain Cancer: Challenges and Lessons Learned », Frontiers in Nutrition, vol. 5,‎ 23 février 2018 (ISSN 2296-861X, PMID 29536011, PMCID PMC5834833, DOI 10.3389/fnut.2018.00011, lire en ligne, consulté le 27 juin 2018).
(en) Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn M, Belanger K, Brandes A, Marosi C, Bogdahn U, Curschmann J, Janzer R, Ludwin S, Gorlia T, Allgeier A, Lacombe D, Cairncross J, Eisenhauer E, Mirimanoff R, « Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma », N Engl J Med, vol. 352, n^o 10,‎ 2005, p. 987-996 (PMID 15758009).

oncolink.org

(en) Gilbert MR, Dignam J, Won M et al. RTOG 0825: phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM), J Clin Oncol, 2013;31(suppl):1.

oxfordjournals.org

neuro-oncology.oxfordjournals.org

(en) Westphal M, Hilt DC, Bortey E et al. « A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma » Neuro Oncol (en). 2003;5:79-88.

sciencedirect.com

Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ; ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial, Lancet Oncol, 2006;7:392-401

wikipedia.org

de.wikipedia.org

(en) Briceño E, Reyes S, Sotelo J, « Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine », Neurosurg Focus (de), vol. 14, n^o 2,‎ 2003, e3. (PMID 15727424) modifier.

fr.wikipedia.org

(en) Briceño E, Reyes S, Sotelo J, « Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine », Neurosurg Focus (de), vol. 14, n^o 2,‎ 2003, e3. (PMID 15727424) modifier.

en.wikipedia.org

(en) Westphal M, Hilt DC, Bortey E et al. « A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma » Neuro Oncol (en). 2003;5:79-88.